Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Neutrophil activation cause of inflammation in canine liver disease
Liver disease is a major health issue in dogs.
Research links high ammonia levels to immune response and inflammation

The Royal (Dick) School of Veterinary Medicine and The Roslin Institute have discovered that high levels of ammonia in dogs with liver disease causes an unregulated immune response by activating neutrophils. The resultant inflammation seen in these cases then further decreases the dog’s overall health.

Inflammatory molecules and high levels of ammonia are commonly discovered in canine liver disease cases and, while treating the liver disease generally results in a decrease in both ammonia and inflammation levels, it has not been known until now what caused the associated inflammation.

Inflammation is a natural and often useful immune response when infection is present, but it is thought that when this response is activated inappropriately, that significant detriment can occur within the body.

Craig R. Breheny, lead scientist involved in the research, states: “Liver disease is a huge issue both in human and veterinary medicine. This study shows how the relationship between ammonia and the inflammatory response strengthens the dog’s role as a model of the human condition”.

Treatment for liver disease is often supportive and the aetiology is largely unknown.

By closely observing the precise activity of these neutrophils, the researchers hope to develop improved treatment and to prevent this unregulated immune response. Breheny concludes: “By understanding how the disease works, new therapies can be investigated to the benefit of both veterinary and human patients”.

 

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk